J1655 – Injection, tinzaparin sodium, 1000 iu
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1655
- Long description
- Injection, tinzaparin sodium, 1000 iu
- Short description
- Tinzaparin sodium injection
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2002
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J1655?
J1655 is a HCPCS Level II code for injection, tinzaparin sodium, 1000 iu. It was discontinued on December 31, 2025.
Does Medicare cover J1655?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1632 – Injection, brexanolone, 1 mg
- J1640 – Injection, hemin, 1 mg
- J1642 – Injection, heparin sodium, (heparin lock flush), per 10 units
- J1643 – Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
- J1644 – Injection, heparin sodium, per 1000 units
- J1645 – Injection, dalteparin sodium, per 2500 iu
- J1650 – Injection, enoxaparin sodium, 10 mg
- J1652 – Injection, fondaparinux sodium, 0.5 mg
- J1670 – Injection, tetanus immune globulin, human, up to 250 units
- J1675 – Injection, histrelin acetate, 10 micrograms
- J1700 – Injection, hydrocortisone acetate, up to 25 mg
- J1710 – Injection, hydrocortisone sodium phosphate, up to 50 mg
- J1720 – Injection, hydrocortisone sodium succinate, up to 100 mg
- J1725 – Injection, hydroxyprogesterone caproate, 1 mg
- J1726 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.